LEADER 01322nam  2200445   450 
001 9910808526803321
005 20200520144314.0
010   $a1-68108-465-1
035   $a(CKB)3710000001375956
035   $a(MiAaPQ)EBC4862907
035   $a(Au-PeEL)EBL4862907
035   $a(CaPaEBR)ebr11387529
035   $a(OCoLC)988175263
035   $a(EXLCZ)993710000001375956
100   $a20170615h20172017  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aNonalcoholic fatty liver disease (NAFLD) /$fedited by Tatjana Abel & Gabriella Lengyel
210  1$aSharjah, United Arab Emirates :$cBentham Science Publishers,$d2017.
210  4$d2017
215   $a1 online resource (178 pages)
311   $a1-68108-466-X 
320   $aIncludes bibliographical references at the end of each chapters and index.
606   $aFatty liver
606   $aInsulin resistance
615  0$aFatty liver.
615  0$aInsulin resistance.
676   $a616.362
702   $aAbel$b Tatjana
702   $aLengyel$b Gabriella
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910808526803321
996   $aNonalcoholic fatty liver disease (NAFLD)$94008227
997   $aUNINA